Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
Clinical trial NCT03334617 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03334617
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2024-09-13
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.